Embedded Files
The global hydrocolloid dressing market size is anticipated to reach USD 2.04 billion by 2030, registering a CAGR of 4.99% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic and acute wounds, rapidly aging population, rising number of diabetic patients, and surge in research and development activities are among the major factors driving the market growth. The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, among the general population is likely to increase the number of patients getting treatment and fuel the adoption of hydrocolloid dressings.
Furthermore, the rising prevalence of acute wounds, such as surgical wounds and burns, is further expected to drive the demand for hydrocolloid wound dressings throughout the projected period. Surgical wounds, for example, are a major problem in general healthcare, according to the Wound Healing Society (WHS). Despite all attempts, Surgical Site Infections (SSI) cause death in 75% of patients globally. As a result, the increased incidence of infections has imposed a significant cost burden on the healthcare business. This is likely to contribute to the launch of advanced products, thus fostering market growth. Clinical uses for several hydrocolloid materials have been proposed in recent years.
Curious about the Hydrocolloid Dressing Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.
Hydrocolloid Dressing Market Report Highlights
• The chronic wound application segment is estimated to dominate the market during the forecast period
• On the basis of end-uses, the hospital segment dominated the market in 2021. The segment’s dominance is attributed to the increasing number of patient admissions for wound injuries and the developing healthcare infrastructure
• North America dominated the marketin 2021 owing to the strong presence of key players and high healthcare expenditure
• Extensive research is now being conducted to study the effectiveness of hydrocolloid dressings. Companies are extensively spending on R&D and are always working on achieving excellent clinical trial outcomes
• For instance, in January 2021, a clinical trial, “Effect of Evidence-based Skin Care & Hydrocolloid Dressing in the Prevention of Nasogastric-related Pressure Injury”, was conducted, which was sponsored by MAIDE YESILYURT, Necmettin Erbakan University
• Thus, robust clinical studies to commercialize innovative hydrocolloid dressing products are expected to drive the growth of the market during the projected period
Hydrocolloid Dressing Market Segmentation
Grand View Research has segmented the global hydrocolloid dressing market on the basis of application, end-use, and region:
Hydrocolloid Dressing Application Outlook (Revenue, USD Million, 2018 - 2030)
• Acute Wounds
o Surgical & Traumatic Wounds
o Burns
• Chronic Wounds
o Diabetic Foot Ulcers
o Pressure Ulcers
o Venous Leg Ulcers
o Other Chronic Wounds
Hydrocolloid Dressing End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Specialty Clinics
• Home Healthcare
• Others
Hydrocolloid Dressing Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
• Asia Pacific
o Japan
o China
o India
o South Korea
o Australia
• Latin America
o Brazil
o Argentina
o Mexico
o Colombia
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
List of Key Players of Hydrocolloid Dressing Market
• Smith & Nephew
• 3M
• Coloplast Corp.
• Convatec Inc.
• Paul Hartmann AG
• B. Braun Melsungen AG
• Cardinal Health
• Covalon Technologies Ltd.
• Dermarite Industries, LLC.
• Medline Industries, Inc.
Order a free sample PDF of the Hydrocolloid Dressing Market Intelligence Study, published by Grand View Research.
Page updated
Google Sites
Report abuse